Find verified Icatibant Acetate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Icatibant Acetate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Icatibant Acetate API.
Alternate Names: Hoechst 140, 325O8467XK, HOE 140, Hoechst-140
CAS No: 138614-30-9
PubChem CID: 6918172
Mol Formula: C61H93N19O15S
Mol Weight: 1364.6 g/mol
IUPAC Name: (2S)-2-[[(2S,3aS,7aS)-1-[(3R)-2-[(2S)-2-[[(2S)-2-[[2-[[(2S,4R)-1-[(2S)-1-[(2S)-2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diamino -Show More
API Description: Icatibant Acetate is the acetate salt form of icatibant, an antagonist of the human bradykinin B2 receptor (B2R), that can be used for the treatment of hereditary angioedema (HAE). Upon administration, icatibant targets and binds to B2R, thereby preventing bradykinin from binding to the B2R. This may prevent bradykinin/B2R-mediated vasodilation, the resulting increase in vascular permeability, and the swelling, inflammation, and pain associated with HAE. This may also prevent or improve pulmonary edema not associated with HAE and improve the associated decrease in blood oxygen levels.
